Search

Search Results
Results 17231 - 17240 of 18476 for breast cancer
  • Fruzaqla
    Drug - 4 Oct 2024
    Consumer Medicine Information (CMI) about Fruzaqla intended for persons living in Australia.
  • Flutamin
    Drug - 27 Sep 2024
    Consumer Medicine Information (CMI) about Flutamin intended for persons living in Australia.
  • Revolutionizing disease prediction: MILTON framework utilizes biobank datasets to identify 3,213 diseases
    News - 17 Sep 2024
    By integrating multi-omics data, MILTON improves disease prediction and biomarker identification, advancing the field of preventative medicine and diagnostics.
  • Voranigo
    Drug - 16 Sep 2024
    Consumer Medicine Information (CMI) about Voranigo intended for persons living in Australia.
  • Columvi
    Drug - 12 Sep 2024
    Consumer Medicine Information (CMI) about Columvi intended for persons living in Australia.
  • Girls exposed to endocrine-disrupting chemicals may be more likely to start puberty early
    News - 10 Sep 2024
    Girls exposed to certain endocrine-disrupting chemicals (EDCs) may be more likely to start puberty early, according to new research published in Endocrinology, the flagship basic science journal of...
  • Cosudex
    Drug - 3 Sep 2024
    Consumer Medicine Information (CMI) about Cosudex intended for persons living in Australia.
  • Calquence tablets
    Drug - 3 Sep 2024
    Consumer Medicine Information (CMI) about Calquence tablets intended for persons living in Australia.
  • Calquence
    Drug - 3 Sep 2024
    Consumer Medicine Information (CMI) about Calquence intended for persons living in Australia.
  • Litfulo
    Drug - 27 Aug 2024
    Consumer Medicine Information (CMI) about Litfulo intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback